Company
LTZ Therapeutics
Lift to Zenith with Novel Myeloid Engager Therapeutics
- Business model
- B2B
- Legal name
- LTZ Therapeutics Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases. Pioneering a novel Myeloid Engager Platform that is guided by reverse translational science, emerging disease biology, and leveraging the power of myeloid cell subsets, particularly macrophages, which offer tremendous potential as an effective therapy to improve the lives of patients with the bold aim to one day eliminate cancer.
Products
- Web
- LTZ-232
- Web
- LTZ-301
- Web
- Myeloid Engager Platform
Loading relationship preview